Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies-Reference-Cited by-同舟云学术

Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies

Published:2013-09 Issue:1-2 Volume:444 Page:329-336
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Barnard Richard J.O.,Howe John A.,Ogert Robert A.,Zeuzem Stefan,Poordad Fred,Gordon Stuart C.,Ralston Robert,Tong Xiao,Sniukiene Vilma,Strizki Julie,Ryan Desmond,Long Jianmin,Qiu Ping,Brass Clifford A.,Albrecht Janice,Burroughs Margaret,Vuocolo Scott,Hazuda Daria J.

Publisher

Elsevier BV

Subject

Virology

Reference29 articles.

1. Boceprevir for previously treated chronic HCVgenotype 1 infection;Bacon;N. Engl. J. Med.,2011

2. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects;Bartels;J. Infect. Dis.,2008

3. Boceprevir an NS3 protease inhibitor of HCV;Berman;Clin. Liver Dis.,2009

4. Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin;Brau;J. Viral. Hepat.,2006

5. Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective;Castro;Virus Res.,2005

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characterization of hepatitis C virus for subtype determination and resistance-associated substitutions detection among Chinese voluntary blood donors;Antiviral Research;2020-09

2. Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1;Clinics and Research in Hepatology and Gastroenterology;2019-11

3. Discovery of Boceprevir, a Ketoamide-Derived HCV NS3 Protease Inhibitor, for Treatment of Genotype 1 Infections;Topics in Medicinal Chemistry;2019

4. Detection of anti-protease inhibitors resistance mutations in HCV strains infecting treatment-naïve chronic patients from Romania;Revista Romana de Medicina de Laborator;2018-10-01

5. Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse;Infection and Drug Resistance;2018-08